PREDNICARBATE Drug Patent Profile
✉ Email this page to a colleague
When do Prednicarbate patents expire, and what generic alternatives are available?
Prednicarbate is a drug marketed by Fougera Pharms and is included in two NDAs.
The generic ingredient in PREDNICARBATE is prednicarbate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prednicarbate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prednicarbate
A generic version of PREDNICARBATE was approved as prednicarbate by FOUGERA PHARMS on March 9th, 2007.
Summary for PREDNICARBATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,695 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PREDNICARBATE |
| What excipients (inactive ingredients) are in PREDNICARBATE? | PREDNICARBATE excipients list |
| DailyMed Link: | PREDNICARBATE at DailyMed |
Recent Clinical Trials for PREDNICARBATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Handok Pharmaceuticals Co., Ltd. | Phase 4 |
| Handok Inc. | Phase 4 |
Pharmacology for PREDNICARBATE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for PREDNICARBATE
US Patents and Regulatory Information for PREDNICARBATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | PREDNICARBATE | prednicarbate | CREAM;TOPICAL | 077287-001 | Sep 19, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Fougera Pharms | PREDNICARBATE | prednicarbate | OINTMENT;TOPICAL | 077236-001 | Mar 9, 2007 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
